{"nct_id":"NCT00511238","title":"Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2007-08","start_date_type":null,"primary_completion_date":"2010-11","primary_completion_date_type":"ACTUAL","completion_date":"2012-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}